← All stocks

GALECTIN THERAPEUTICS INC

GALT No buying or selling

CIK 0001133416 #3361 in the set updated 17 Sep 2026

Bought (1 mo)

$0.00

out of their own pocket, the only kind of buying there is

Sold (1 mo)

$0.00

$0.00 on a plan · $0.00 straight out of an exercise

Sold at will

$0.00

0 of 0 sales

Net

$0.00

$0.00 against sales at will

By person

10 insiders · 0 transactions

Insider

Role

Bought

Sold

Net

Holding

Worth

Change

Uihlein Richard E

Director

—

55,046,519

$282.12M

+166.9%

10X Fund, L.P. entity

10% owner

—

5,614,457

$28.78M

−5.0%

CZIRR JAMES C

10% owner

—

1,045,541

$5.36M

+41.0%

LEWIS JOEL

President and CEO

—

832,592

$4.27M

−6.3%

FREEMAN KEVIN D

Director

—

135,269

$693.28K

+30.7%

ELDRED KARY

Director

—

65,682

$336.63K

+34.0%

Zordani Richard A. Jr.

Director

—

42,083

$215.68K

+31.2%

Shlevin Harold H.

Director

—

26,123

$133.89K

−7.1%

CALLICUTT JACK W

Chief Financial Officer

—

7,614

$39.02K

0.0%

Jamil Khurram

Chief Medical Officer

—

$0.00

—

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.

Individual transactions

Nothing of that kind in this period.

What was left out

Form 4 filings counted 0

Amendments (4/A) skipped 0

Filings about a different issuer 0

Unreadable filings 0

Joint filings 0

Sales on a Rule 10b5-1 plan 0

Sales straight out of an exercise 0

Sales at will 0

Transactions with no price 0

Shares from compensation/vesting 0

History held since 24 Oct 2016